NFA
AMPH icon

Nationwide Fund Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Nationwide Fund Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-48,466
Closed -$866K – 108
2017
Q3 		$866K Sell
48,466
-800
-2% -$13.2K ﹤0.01% 1882
2017
Q2 		$880K Buy
49,266
+5,233
+12% +$83K ﹤0.01% 1856
2017
Q1 		$638K Sell
44,033
-5,056
-10% -$79.5K ﹤0.01% 2025
2016
Q4 		$904K Buy
49,089
+449
+0.9% +$8.73K ﹤0.01% 1843
2016
Q3 		$923K Sell
48,640
-2,600
-5% -$47.2K ﹤0.01% 1835
2016
Q2 		$826K Buy
51,240
+11,915
+30% +$168K ﹤0.01% 1856
2016
Q1 		$472K Buy
39,325
+525
+1% +$6.19K ﹤0.01% 2125
2015
Q4 		$552K Buy
38,800
+139
+0.4% +$1.84K ﹤0.01% 2062
2015
Q3 		$452K Hold
38,661
– – ﹤0.01% 2174
2015
Q2 		$680K Sell
38,661
-1,444
-4% -$22.5K ﹤0.01% 2074
2015
Q1 		$600K Sell
40,105
-7,667
-16% -$102K ﹤0.01% 2145
2014
Q4 		$555K Buy
47,772
+1,744
+4% +$19K ﹤0.01% 2124
2014
Q3 		$536K Buy
+46,028
New +$479K ﹤0.01% 2168

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nationwide Fund Advisors's AMPH Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2017, closing a stake of 48,466 shares — an estimated $866K sold.

Nationwide Fund Advisors first reported a position in AMPH in Q3 2014 and held it in 13 quarters. The position peaked at $923K in Q3 2016. 109 funds tracked by Wall St. Rank hold AMPH as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Amphastar Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 48,466 Amphastar Pharmaceuticals shares in Q4 2017, an estimated $866K.
  • Nationwide Fund Advisors first reported a position in Amphastar Pharmaceuticals in Q3 2014 and held it in 13 quarters.
  • Nationwide Fund Advisors's Amphastar Pharmaceuticals position peaked at $923K in Q3 2016.
  • 109 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.